- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/539 - ImmunoassayBiospecific binding assayMaterials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent
Patent holdings for IPC class G01N 33/539
Total number of patents in this class: 47
10-year publication summary
|
1
|
7
|
6
|
2
|
4
|
4
|
5
|
6
|
2
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbott Point Of Care Inc. | 319 |
4 |
| Genzyme Corporation | 1369 |
4 |
| Cytosed, Inc. | 4 |
2 |
| University of Utah Research Foundation | 1860 |
2 |
| Washington University | 1736 |
2 |
| Wavesense, Inc. | 29 |
2 |
| Vision Diagnostics, Inc. | 8 |
2 |
| Medicines Discovery Catapult Limited | 5 |
2 |
| Merck Sharp & Dohme LLC | 3735 |
2 |
| The Regents of the University of California | 20720 |
1 |
| The Johns Hopkins University | 5875 |
1 |
| Tsinghua University | 6212 |
1 |
| Sumitomo Rubber Industries, Ltd. | 4723 |
1 |
| The Board of Trustees of the University of Illinois | 2750 |
1 |
| Icemos Technology Ltd. | 50 |
1 |
| InDevR, Inc. | 29 |
1 |
| Korea Center for Disease Control and Prevention | 14 |
1 |
| Korea Institute of Radiological & Medical Sciences | 148 |
1 |
| Lankenau Institute for Medical Research | 100 |
1 |
| Lankenau Institute of Medical Research | 7 |
1 |
| Other owners | 14 |